BRPI0819908A2 - Formulações de soluções oftálmicas ou ópticas tópicas contendo cloridato de moxifloxacina e fosfato de dexametasona - Google Patents
Formulações de soluções oftálmicas ou ópticas tópicas contendo cloridato de moxifloxacina e fosfato de dexametasonaInfo
- Publication number
- BRPI0819908A2 BRPI0819908A2 BRPI0819908-6A BRPI0819908A BRPI0819908A2 BR PI0819908 A2 BRPI0819908 A2 BR PI0819908A2 BR PI0819908 A BRPI0819908 A BR PI0819908A BR PI0819908 A2 BRPI0819908 A2 BR PI0819908A2
- Authority
- BR
- Brazil
- Prior art keywords
- chloridate
- formulations
- solutions containing
- topical ophthalmic
- dexamethasone phosphate
- Prior art date
Links
- 229960004833 dexamethasone phosphate Drugs 0.000 title 1
- VQODGRNSFPNSQE-CXSFZGCWSA-N dexamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-CXSFZGCWSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- FABPRXSRWADJSP-MEDUHNTESA-N moxifloxacin Chemical compound COC1=C(N2C[C@H]3NCCC[C@H]3C2)C(F)=CC(C(C(C(O)=O)=C2)=O)=C1N2C1CC1 FABPRXSRWADJSP-MEDUHNTESA-N 0.000 title 1
- 229960003702 moxifloxacin Drugs 0.000 title 1
- 230000003287 optical effect Effects 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99045207P | 2007-11-27 | 2007-11-27 | |
| PCT/US2008/084532 WO2009070530A1 (en) | 2007-11-27 | 2008-11-24 | Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0819908A2 true BRPI0819908A2 (pt) | 2015-05-19 |
Family
ID=40467276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0819908-6A BRPI0819908A2 (pt) | 2007-11-27 | 2008-11-24 | Formulações de soluções oftálmicas ou ópticas tópicas contendo cloridato de moxifloxacina e fosfato de dexametasona |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7888370B2 (pt) |
| EP (1) | EP2211835A1 (pt) |
| JP (1) | JP2011504881A (pt) |
| KR (1) | KR20100090278A (pt) |
| CN (1) | CN101861139A (pt) |
| AR (1) | AR069438A1 (pt) |
| AU (1) | AU2008329876A1 (pt) |
| BR (1) | BRPI0819908A2 (pt) |
| CA (1) | CA2703913A1 (pt) |
| CL (1) | CL2008003536A1 (pt) |
| MX (1) | MX2010004953A (pt) |
| RU (1) | RU2010126096A (pt) |
| TW (1) | TW200932285A (pt) |
| UY (1) | UY31494A1 (pt) |
| WO (1) | WO2009070530A1 (pt) |
| ZA (1) | ZA201002884B (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| WO2013065029A1 (en) * | 2011-11-04 | 2013-05-10 | Micro Labs Limited | Fixed dose combination containing moxifloxacin and prednisolone for treatment of ocular infections |
| ITMI20122002A1 (it) * | 2012-11-26 | 2014-05-27 | Farmacologico Milanese Srl Lab | Preparazioni farmaceutiche liquide stabilizzate |
| WO2014119643A1 (ja) * | 2013-01-31 | 2014-08-07 | 千寿製薬株式会社 | 澄明な水性液剤 |
| US20160279055A1 (en) | 2013-07-22 | 2016-09-29 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20150164882A1 (en) | 2013-07-22 | 2015-06-18 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| US11452732B2 (en) * | 2015-09-05 | 2022-09-27 | Randal Davis | Homogeneous ophthalmic composition |
| US10130639B1 (en) * | 2015-09-05 | 2018-11-20 | Randal Davis | Homogeneous ophthalmic composition |
| GR1008921B (el) * | 2015-12-10 | 2017-01-12 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον δεξαμεθαζονη |
| CA3023243C (en) * | 2016-05-06 | 2020-01-21 | Imprimis Pharmaceuticals, Inc. | Pharmaceutical ophthalmic compositions and methods for fabricating thereof |
| US20190216830A1 (en) * | 2017-10-06 | 2019-07-18 | Aciont Inc. | Ophthalmic compositions |
| CN113750041A (zh) * | 2020-06-04 | 2021-12-07 | 成都倍特药业股份有限公司 | 一种地塞米松磷酸钠液体制剂及其制备方法 |
| CN116270662A (zh) * | 2021-12-03 | 2023-06-23 | 苏州欧康维视生物科技有限公司 | 盐酸莫西沙星地塞米松磷酸钠滴眼液 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2939873A (en) * | 1959-01-26 | 1960-06-07 | Merck & Co Inc | Synthesis of steroid phosphates |
| US5414011A (en) * | 1987-09-11 | 1995-05-09 | Syntex (U.S.A.) Inc. | Preservative system for ophthalmic formulations |
| US5407926A (en) * | 1987-12-29 | 1995-04-18 | Alcon Laboratories, Inc. | Ophthalmic composition |
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| US5397771A (en) * | 1990-05-10 | 1995-03-14 | Bechgaard International Research And Development A/S | Pharmaceutical preparation |
| ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
| ES2079994B1 (es) * | 1992-10-07 | 1996-08-01 | Cusi Lab | Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica. |
| US6716830B2 (en) * | 1998-09-30 | 2004-04-06 | Alcon, Inc. | Ophthalmic antibiotic compositions containing moxifloxacin |
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
-
2008
- 2008-11-24 BR BRPI0819908-6A patent/BRPI0819908A2/pt not_active IP Right Cessation
- 2008-11-24 CA CA2703913A patent/CA2703913A1/en not_active Abandoned
- 2008-11-24 KR KR1020107011695A patent/KR20100090278A/ko not_active Withdrawn
- 2008-11-24 WO PCT/US2008/084532 patent/WO2009070530A1/en not_active Ceased
- 2008-11-24 MX MX2010004953A patent/MX2010004953A/es not_active Application Discontinuation
- 2008-11-24 CN CN200880116678A patent/CN101861139A/zh active Pending
- 2008-11-24 JP JP2010535114A patent/JP2011504881A/ja not_active Withdrawn
- 2008-11-24 EP EP08855506A patent/EP2211835A1/en not_active Withdrawn
- 2008-11-24 RU RU2010126096/15A patent/RU2010126096A/ru unknown
- 2008-11-24 US US12/276,823 patent/US7888370B2/en active Active
- 2008-11-24 AU AU2008329876A patent/AU2008329876A1/en not_active Abandoned
- 2008-11-26 TW TW097145700A patent/TW200932285A/zh unknown
- 2008-11-27 UY UY31494A patent/UY31494A1/es not_active Application Discontinuation
- 2008-11-27 CL CL2008003536A patent/CL2008003536A1/es unknown
- 2008-11-27 AR ARP080105164A patent/AR069438A1/es not_active Application Discontinuation
-
2010
- 2010-04-23 ZA ZA2010/02884A patent/ZA201002884B/en unknown
- 2010-12-14 US US12/967,250 patent/US8173671B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20110082125A1 (en) | 2011-04-07 |
| CN101861139A (zh) | 2010-10-13 |
| JP2011504881A (ja) | 2011-02-17 |
| TW200932285A (en) | 2009-08-01 |
| US7888370B2 (en) | 2011-02-15 |
| CL2008003536A1 (es) | 2009-10-16 |
| EP2211835A1 (en) | 2010-08-04 |
| WO2009070530A1 (en) | 2009-06-04 |
| US8173671B2 (en) | 2012-05-08 |
| UY31494A1 (es) | 2009-03-02 |
| RU2010126096A (ru) | 2012-01-10 |
| US20090137539A1 (en) | 2009-05-28 |
| AR069438A1 (es) | 2010-01-20 |
| CA2703913A1 (en) | 2009-06-04 |
| MX2010004953A (es) | 2010-08-10 |
| KR20100090278A (ko) | 2010-08-13 |
| ZA201002884B (en) | 2011-07-27 |
| AU2008329876A1 (en) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0819908A2 (pt) | Formulações de soluções oftálmicas ou ópticas tópicas contendo cloridato de moxifloxacina e fosfato de dexametasona | |
| FR22C1060I2 (fr) | Imidazotriazines et imidazopyrimidines utilisees en tant qu'inhibiteurs de kinases | |
| IL211448A (en) | Use of bio-enhancers and/or photo-enhancers for preparing ophthalmic compositions comprising riboflavin or riboflavin phosphate for treating corneal ectasic disorders by corneal cross-linking | |
| IL251768A0 (en) | Auris formulations for treating otic diseases and conditions | |
| HRP20182135T1 (hr) | Pripravci za i postupci liječenja poremećaja povezanih s ige | |
| EP2432473A4 (en) | PYRAZOLOPYRIMIDINES AND CORRESPONDING HETEROCYCLES AS KINASE INHIBITORS | |
| DK2376506T3 (da) | Flydende sammensætning indeholdende fosforsyre- eller thiofosforsyretriamidderivat og anvendelse heraf | |
| SMT201600080B (it) | Inibitori di chinasi janus per il trattamento di occhio secco e altre malattie oculari | |
| BR112013008140A2 (pt) | "compostos imidazotriazinona". | |
| EP2773251A4 (en) | DISPENSER AND POLLUTION SENSOR | |
| PT2245145T (pt) | Fabrico de enzimas sulfatase lisossómicas humanas altamente fosforiladas e suas utilizações | |
| EP2179060A4 (en) | DIFFERENTIAL EXPRESSION OF MICROSIS IN FUNCTIONING COMPARED TO NON-FUNCTIONING HUMAN HEARTS | |
| EP2259678A4 (en) | PROTEIN KINASE MODULATORS | |
| PL15177166T1 (pl) | Modulatory receptora s1p do leczenia stwardnienia rozsianego | |
| HRP20190059T1 (hr) | Pripravci za liječenje boli i/ili upale | |
| EP2187743A4 (en) | FORMULATIONS FOR THE TREATMENT OF DISEASES OR EYE DISORDERS | |
| EP2547676A4 (en) | MODULATORS OF THE HEC1 ACTIVITY AND METHOD THEREFOR | |
| EP2106252A4 (en) | NIGHT VISION GLASSES | |
| BRPI0820693A2 (pt) | Fotoestabilidade aumentada de avobenzona na presença de óxido de zinco usando emulsificantes à base de fosfato | |
| PL2427193T3 (pl) | Zastosowanie inhibitorów pde7 do leczenia zaburzeń ruchu | |
| FR2938934B1 (fr) | Verre de lunettes procurant une vision ophtalmique et une vision supplementaire | |
| DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
| BRPI0909763A2 (pt) | soluções oftálmicas tamponadas com fosfato que apresentam eficácia otimizada | |
| BR112013016337A2 (pt) | sistema de tratamento médico com fibra óptica | |
| BR112014009479A2 (pt) | composição líquida e método de desinfecção da superfície externa de um corpo animal ou humano |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |